Terms: = Leukemia AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
113 results:
1. Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid leukemia and Overcoming Resistance of FLT3 Inhibitors.
Wang J; Rong Q; Ye L; Fang B; Zhao Y; Sun Y; Zhou H; Wang D; He J; Cui Z; Zhang Q; Kang D; Hu L
J Med Chem; 2024 May; 67(9):7197-7223. PubMed ID: 38655686
[TBL] [Abstract] [Full Text] [Related]
2. LINC01686 affects LPS-induced cytokine expression via the miR-18a-5p/a20/STAT1 axis in THP-1 cells.
Baek J; Shin HS; Suk K; Lee WH
Immun Inflamm Dis; 2024 Apr; 12(4):e1234. PubMed ID: 38578001
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of a20 and CYLD.
Hoang NH; Huyen NT; Trang DT; Canh NX; Mao CV; Sopjani M; Vuong NB; Xuan NT
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):47-53. PubMed ID: 37114273
[TBL] [Abstract] [Full Text] [Related]
4. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
5. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1
Del Rio ML; de Juan CY; Roncador G; Caleiras E; Álvarez-Esteban R; Pérez-Simón JA; Rodriguez-Barbosa JI
Front Immunol; 2023; 14():1113858. PubMed ID: 37033927
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Wang X; Chen C; Vuong D; Rodriguez-Rodriguez S; Lam V; Roleder C; Wang JH; Kambhampati S; Berger A; Pennock N; Torka P; Hernandez-Ilizaliturri F; Siddiqi T; Wang L; Xia Z; Danilov AV
Leukemia; 2023 Jun; 37(6):1324-1335. PubMed ID: 37031300
[TBL] [Abstract] [Full Text] [Related]
7. Unraveling the genetics of transformed splenic marginal zone lymphoma.
Grau M; López C; Navarro A; Frigola G; Nadeu F; Clot G; Bastidas-Mora G; Alcoceba M; Baptista MJ; Blanes M; Colomer D; Costa D; Domingo-Domènech E; Enjuanes A; Escoda L; Forcada P; Giné E; Lopez-Guerra M; Ramón O; Rivas-Delgado A; Vicente Folch L; Wotherspoon A; Climent F; Campo E; López-Guillermo A; Matutes E; Beà S
Blood Adv; 2023 Jul; 7(14):3695-3709. PubMed ID: 36995085
[TBL] [Abstract] [Full Text] [Related]
8. Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Tatarczuch M; Waltham M; Shortt J; Polekhina G; Hawkes EA; Ho SJ; Trotman J; Brasacchio D; Co M; Li J; Ramakrishnan V; Dunne K; Opat SS; Gregory GP
Blood Adv; 2023 Jul; 7(14):3531-3539. PubMed ID: 36947202
[TBL] [Abstract] [Full Text] [Related]
9. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.
Uribe-Herranz M; Beghi S; Ruella M; Parvathaneni K; Salaris S; Kostopoulos N; George SS; Pierini S; Krimitza E; Costabile F; Ghilardi G; Amelsberg KV; Lee YG; Pajarillo R; Markmann C; McGettigan-Croce B; Agarwal D; Frey N; Lacey SF; Scholler J; Gabunia K; Wu G; Chong E; Porter DL; June CH; Schuster SJ; Bhoj V; Facciabene A
Mol Ther; 2023 Mar; 31(3):686-700. PubMed ID: 36641624
[TBL] [Abstract] [Full Text] [Related]
10. Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.
Dusetzina SB; Huskamp HA; Qin X; Keating NL
JAMA; 2022 Oct; 328(15):1515-1522. PubMed ID: 36255428
[TBL] [Abstract] [Full Text] [Related]
11. tnfaip3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.
Chen C; Zhou L; Zhu L; Luo G; Wang L; Zeng C; Zhou H; Li Y
Cancer Med; 2023 Feb; 12(4):3952-3961. PubMed ID: 36056685
[TBL] [Abstract] [Full Text] [Related]
12. Differential Engraftment of Parental a20 PD-L1 WT and PD-L1 KO leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance.
Del Rio ML; Perez-Simon JA; Rodriguez-Barbosa JI
Front Immunol; 2022; 13():887348. PubMed ID: 35795681
[TBL] [Abstract] [Full Text] [Related]
13. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.
Wu G; Xu Y; Schultz RD; Chen H; Xie J; Deng M; Liu X; Gui X; John S; Lu Z; Arase H; Zhang N; An Z; Zhang CC
Nat Cancer; 2021 Nov; 2(11):1170-1184. PubMed ID: 35122056
[TBL] [Abstract] [Full Text] [Related]
14. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
[TBL] [Abstract] [Full Text] [Related]
15. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
Isola I; Brasó-Maristany F; Moreno DF; Mena MP; Oliver-Calders A; Paré L; Rodríguez-Lobato LG; Martin-Antonio B; Cibeira MT; Bladé J; Rosiñol L; Prat A; Lozano E; Fernández de Larrea C
Front Immunol; 2021; 12():792609. PubMed ID: 34880879
[TBL] [Abstract] [Full Text] [Related]
16. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
[TBL] [Abstract] [Full Text] [Related]
17. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract] [Full Text] [Related]
18. PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related molecules.
Liang M; Gong D; Wang L; Liang X; Meng J; Huang W; Zhou J
Cancer Treat Res Commun; 2021; 28():100437. PubMed ID: 34425470
[TBL] [Abstract] [Full Text] [Related]
19. Thyroid MALT lymphoma: self-harm to gain potential T-cell help.
Wu F; Watanabe N; Tzioni MM; Akarca A; Zhang C; Li Y; Chen Z; Cucco F; Carmell N; Noh JY; Ito K; Dobson R; Moody S; Yao W; Zhang W; Liu W; Liu H; Okosun J; Chott A; Bi Y; Chuang SS; Raderer M; Li JY; Marafioti T; Du MQ
Leukemia; 2021 Dec; 35(12):3497-3508. PubMed ID: 34021249
[TBL] [Abstract] [Full Text] [Related]
20. Connection of BANK1, Tolerance, Regulatory B cells, and Apoptosis: Perspectives of a Reductionist Investigation.
Le Berre L; Chesneau M; Danger R; Dubois F; Chaussabel D; Garand M; Brouard S
Front Immunol; 2021; 12():589786. PubMed ID: 33815360
[TBL] [Abstract] [Full Text] [Related]
[Next]
